Paying user area
Try for free
Bristol-Myers Squibb Co. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Balance Sheet: Assets
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Net Profit Margin since 2005
- Debt to Equity since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Bristol-Myers Squibb Co. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The financial data reveals significant volatility in both reported and adjusted net earnings attributable to the company over the analyzed five-year period.
- 2020
- Both reported and adjusted net earnings exhibited substantial losses, each approximately -9 billion US dollars. This indicates a challenging financial year with considerable negative performance.
- 2021
- There was a dramatic turnaround in earnings, with reported and adjusted net income shifting to gains near 7 billion US dollars. This sharp improvement suggests effective operational recovery or extraordinary positive impacts during this year.
- 2022
- The company maintained positive net earnings, although there was a noticeable decline compared to 2021, with values around 6.3 billion US dollars for both reported and adjusted figures. This may reflect slight deceleration in growth or increased expenses impacting profitability.
- 2023
- The positive trend reversed with an increase in net earnings to about 8 billion US dollars for both reported and adjusted figures, indicating renewed strength and enhanced profitability during the year.
- 2024
- A significant drop occurred, with reported and adjusted net earnings returning to losses near -9 billion US dollars, effectively negating the gains from prior years. This sharp reversal points to potential extraordinary charges, operational difficulties, or market challenges.
Overall, the company's profitability displayed extreme fluctuations across the years, characterized by two major loss years at the beginning and end of the period, bracketed by three years of substantial profits. The close alignment of reported and adjusted net earnings throughout indicates consistent reconciliation adjustments without material divergence. These trends highlight the company's exposure to volatile financial outcomes potentially driven by one-time events or significant operational shifts during the timeframe.
Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The financial performance indicators over the five-year period demonstrate notable fluctuations, with significant variations observed in the years 2020 and 2024. The analysis distinguishes reported metrics from adjusted metrics, both of which exhibit closely aligned trends throughout the timeline.
- Net Profit Margin
- The reported net profit margin shows a steep negative value of -21.2% at the end of 2020, signaling a considerable loss during that year. This margin rebounded sharply in 2021 with a positive 15.08%, maintaining positive territory through 2022 (13.71%) and 2023 (17.83%). However, there is a pronounced reversal in 2024, plummeting back to a negative margin of -18.53%. The adjusted net profit margin mirrors this pattern almost identically, suggesting consistent underlying profit trends when excluding non-recurring or exceptional items.
- Return on Equity (ROE)
- The reported ROE follows a similar trajectory, beginning with a significant negative return of -23.84% in 2020, indicating a loss relative to shareholders’ equity. The company achieved positive returns in the subsequent three years: 19.46% in 2021, 20.37% in 2022, and peaking at 27.27% in 2023. A marked deterioration occurs in 2024, with ROE sharply declining to -54.78%, reflecting substantial equity losses. Adjusted ROE figures are nearly indistinguishable from the reported ones, reinforcing the consistency of the equity return trend despite accounting adjustments.
- Return on Assets (ROA)
- The reported ROA starts with a negative return of -7.61% in 2020, signifying unprofitable asset utilization. It improves gradually from 6.4% in 2021 to 6.53% in 2022, and further to 8.43% in 2023, reflecting efficient asset usage and improved operational profitability during this period. Like the other metrics, 2024 shows a sharp negative shift to -9.66%. The adjusted ROA closely aligns with these reported values throughout, indicating that adjustments have minimal impact on asset return measurements.
Overall, the data highlights a recovery phase from significant losses in 2020, with increasing profitability and returns sustained through 2021 to 2023. The consistent closeness between reported and adjusted figures suggests stable core financial performance during these years. The year 2024 stands out as an anomaly with all key metrics sharply reversing into negative territory, implying considerable financial challenges or extraordinary events impacting profitability, equity returns, and asset utilization.
Bristol-Myers Squibb Co., Profitability Ratios: Reported vs. Adjusted
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Net profit margin = 100 × Net earnings (loss) attributable to BMS ÷ Revenues
= 100 × ÷ =
2 Adjusted net profit margin = 100 × Adjusted net earnings (loss) attributable to BMS ÷ Revenues
= 100 × ÷ =
The financial data reveals significant volatility in both reported and adjusted net earnings attributable to the company over the five-year period. Starting with a substantial net loss in 2020, the company experienced a recovery in 2021, with positive earnings exceeding 6 billion US dollars. This positive trend continued into 2022 and 2023, although earnings fluctuated slightly, showing growth in 2023 compared to 2022. However, the company again faced a sharp downturn in 2024, recording a net loss comparable in magnitude to that in 2020.
Examining the net profit margins, the patterns align closely with the earnings trajectory. The reported net profit margin was notably negative in 2020, reflecting the reported loss status. It then transitioned into positive territory in 2021 and remained positive through 2023, showing improvement in profitability particularly in 2023. Despite this recovery, the margin fell back into negative territory in 2024, indicating a loss relative to revenue similar to the initial year in the analysis.
Both reported and adjusted figures mirror each other closely in terms of amount and margin percentages across all years. This close alignment suggests that adjustments made to the earnings were minimal or consistent, maintaining a similar profitability profile under both reported and adjusted frameworks.
Overall, the data indicates a cyclical profit pattern with an initial loss followed by three years of recovery and profitability, and then a return to loss in the latest year. This volatility suggests the company may be operating in a dynamic environment with significant fluctuations in earnings capacity or one-time impacts affecting net results. The consistent tracking between reported and adjusted figures also implies reliability in reported earnings without substantial non-recurring adjustments over the period analyzed.
- Earnings Trend
- Initial loss in 2020, positive recovery and modest growth from 2021 to 2023, return to loss in 2024.
- Net Profit Margin Trend
- Negative margin in 2020 and 2024, positive margins with improvement from 2021 through 2023.
- Reported vs Adjusted Figures
- High consistency between reported and adjusted earnings and margins, indicating minimal adjustment effects.
- Overall Interpretation
- The results demonstrate earnings volatility with periods of profitability interrupted by significant losses, suggesting cyclical or external influences on financial performance.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 ROE = 100 × Net earnings (loss) attributable to BMS ÷ Total BMS shareholders’ equity
= 100 × ÷ =
2 Adjusted ROE = 100 × Adjusted net earnings (loss) attributable to BMS ÷ Total BMS shareholders’ equity
= 100 × ÷ =
The financial data exhibits significant volatility in both reported and adjusted net earnings, as well as in return on equity (ROE) metrics over the analyzed period.
- Net Earnings (Loss) Attributable to the Company
- The reported net earnings started with a substantial loss of -9015 million USD in 2020, followed by a strong recovery to positive values in 2021 through 2023, peaking at 8025 million USD in 2023. However, there is a dramatic reversal in 2024, where the net earnings fall back into a large loss of -8948 million USD. The adjusted net earnings closely mirror the reported figures throughout the period, indicating that adjustments have minimal impact on the trend.
- Return on Equity (ROE)
- The reported ROE follows a pattern consistent with net earnings. It starts at a deeply negative -23.84% in 2020, improves significantly to a positive range between 19.46% and 27.27% from 2021 to 2023, demonstrating improved profitability and equity utilization during these years. In 2024, the ROE plunges sharply to -54.78%, reflecting the severe loss reported in the same year. The adjusted ROE values correspond almost exactly with reported ROE, indicating stable adjustments.
Overall, the data reveals a cycle of substantial losses, recovery with positive profitability, followed by another pronounced loss in the final year. This pattern points to considerable financial instability or external impacts affecting the company's performance and equity returns. The near-identical values for reported and adjusted figures suggest that extraordinary items or one-time adjustments did not significantly alter the reported financial outcomes during this time.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 ROA = 100 × Net earnings (loss) attributable to BMS ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Adjusted net earnings (loss) attributable to BMS ÷ Total assets
= 100 × ÷ =
- Net Earnings (Loss) Attributable to the Company
- The reported net earnings showed significant volatility over the examined period. A substantial loss of approximately $9.0 billion was observed at the end of 2020, followed by a sharp recovery to around $7.0 billion profit in 2021. Subsequently, the earnings slightly decreased but remained positive in 2022 with approximately $6.3 billion and then improved to about $8.0 billion in 2023. However, the trend reversed again in 2024, with a notable return to a large loss of approximately $8.9 billion.
- Adjusted Net Earnings (Loss) Attributable to the Company
- The adjusted net earnings followed a trajectory nearly identical to the reported figures, indicating that adjustments had minimal impact on the overall earnings pattern. Starting with a substantial loss in 2020, followed by positive earnings in 2021 through 2023, and ending with a significant loss again in 2024, the adjusted earnings confirm the volatile performance observed in the reported data.
- Return on Assets (ROA)
- Both the reported and adjusted ROA mirrored the net earnings trend, illustrating considerable fluctuation. The company experienced strongly negative returns in 2020, with ROA close to -7.6%, then improved to positive territory around 6.4% in 2021. This positive trend continued into 2022 and 2023, with ROA modestly increasing to approximately 6.5% and 8.4%, respectively. Nevertheless, in 2024 the ROA sharply declined to a negative figure near -9.7%, reflecting the substantial losses incurred during that year.
- Overall Observations
- The financial performance over these periods is characterized by pronounced cyclical swings between considerable losses and strong profitability. The alignment of both reported and adjusted figures suggests consistency in the underlying financial performance despite any accounting adjustments. The fluctuations in ROA support the observation of instability in asset utilization efficiency, culminating in a significant downturn in the most recent year reported.